Aggregation kinetics define the temporal window of IAPP proteotoxicity
Proceedings of the National Academy of Sciences · 11.08.2026 · 123 (32)
DOI: 10.1073/pnas.2615786123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 06.08.2026. Verfasst von Annette Plesner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, University Hospital-Rigshospitalet, Copenhagen 2200, Denmark. Hauptthemen laut MEDLINE: Islet Amyloid Polypeptide, Insulin-Secreting Cells, Protein Aggregates, Protein Aggregation, Pathological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, American Heart Association (AHA), HHS | NIH (NIH).
Abstract (Originalsprache)
Aggregation of islet amyloid polypeptide (IAPP) to form amyloid contributes to β-cell dysfunction in type 2 diabetes, yet the identity and temporal persistence of the toxic species is unresolved. Competing models attribute toxicity to mature fibrils, fibril growth, or transient prefibrillar intermediates formed during the lag phase or via secondary nucleation. Here, we directly test these models by combining time-resolved β-cell functional assays with concurrent biophysical measurements of IAPP aggregation across multiple perturbations and sequence variants. Across 22 independent experiments spanning more than a 450-fold range in lag times, we find that maximal toxicity occurs during the lag phase and declines as fibrils accumulate. The duration of β-cell dysfunction scales linearly with lag phase length, establishing aggregation kinetics as a quantitative predictor of the onset, peak, and termination of toxicity. Perturbations that alter aggregation kinetics, including concentration, temperature, and sequence, predictably shift the temporal window of toxicity. The diabetes-associated S20G variant produces higher peak toxicity over a compressed time window, whereas the slower-aggregating variants examined prolong toxicity without increasing its magnitude. These results resolve competing models by demonstrating that transient lag-phase intermediates, rather than growth phase processes or mature fibrils, dominate β-cell dysfunction, and establish aggregation kinetics as a predictor of the timing and duration of cellular exposure to toxic intermediates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology, University Hospital-Rigshospitalet, Copenhagen 2200, Denmark.
- Department of Chemistry, Stony Brook University, Stony Brook, NY 11794-3400.
- Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY 11794.
ORCID-Profile: Annette Plesner, Andisheh Abedini
Förderung
- NIGMS NIH HHS
- American Heart Association (AHA)
- HHS | NIH (NIH)
Zitieren
APA
Plesner, A., Cao, P., Raleigh, D. P., & Abedini, A. (2026). Aggregation kinetics define the temporal window of IAPP proteotoxicity. Proceedings of the National Academy of Sciences, 123(32). https://doi.org/10.1073/pnas.2615786123
Vancouver
Plesner A, Cao P, Raleigh DP, Abedini A. Aggregation kinetics define the temporal window of IAPP proteotoxicity. Proceedings of the National Academy of Sciences. 2026;123(32). doi:10.1073/pnas.2615786123
BibTeX
@article{Plesner2026,
author = {Plesner, Annette and Cao, Ping and Raleigh, Daniel P and Abedini, Andisheh},
title = {Aggregation kinetics define the temporal window of IAPP proteotoxicity},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {32},
doi = {10.1073/pnas.2615786123}
}
EUVIMED